Non-derivatizing Tandem Mass Spectrometry Assay for Expanded Newborn Screening and Cutoffs for Preterm Neonates

참고문헌 (6)

1. Rappold Brian A., "Review of the Use of Liquid Chromatography-Tandem Mass Spectrometry in Clinical Laboratories: Part I-Development", Annals of Laboratory Medicine, 42(2), pp.121~140 (2022), 대한진단검사의학회[DOI]
2. Rappold Brian A., "Review of the Use of Liquid Chromatography-Tandem Mass Spectrometry in Clinical Laboratories: Part II–Operations", Annals of Laboratory Medicine, 42(5), pp.531~557 (2022), 대한진단검사의학회[DOI]
3. Chace DH, "The application of tandem mass spectrometry to neonatal screening for inherited disorders of intermediary metabolism", Annu Rev Genomics Hum Genet, 3, pp.17~45 (2002)
4. Wilcken B, "Screening newborns for inborn errors of metabolism by tandem mass spectrometry", N Engl J Med, 348, pp.2304~2312 (2003)
5. Zytkovicz TH, "Tandem mass spectrometric analysis for amino, organic, and fatty acid disorders in newborn dried blood spots: a two-year summary from the New England Newborn Screening Program", Clin Chem, 47, pp.1945~1955 (2001)
6. 이범기, "Comprehensive Evaluation of the NeoBase 2 Non-derivatized MSMS Assay and Exploration of Analytes With Significantly Different Concentrations Between Term and Preterm Neonates", Annals of Laboratory Medicine, 43(2), pp.153~166 (2023), 대한진단검사의학회[DOI]

관련 논문AI추천